Qingfuji Trading
Retatrutide
Finnrick tested 3 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Qingfuji Trading between 30 Dec 2025 and 5 Jun 2026. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Qingfuji Trading
Retatrutide
Tested 3 Samples
Last test 5 Jun 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Qingfuji Trading
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
5 Jun 2026
First
30 Dec 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 5 Jun 2026 | View | 30mg | 26.7mg | -11.0% | 99.90% | (no batch ID) | Red label / Silver crimp / Black cap | Lab E | Public | |
| 30 Dec 2025 | View | 50mg | 39.7mg | -20.6% | 99.95% | (no batch ID) | (no data) | Lab E | Public | |
| 30 Dec 2025 | View | 30mg | 35.5mg | +18.3% | 99.90% | (no batch ID) | (no data) | Lab E | Public | |